The Controversies Surrounding Bevacizumab and Ranibizumab
Ee Vien Low & Faridah Aryani Md. Yusof · Advances in Research · 2014
Age-related macular degeneration (AMD) is a leading cause of visual impairment and blindness. Both bevacizumab and ranibizumab are anti-vascular endothelial growth factors used for treatment of AMD. However the use of bevacizumab remains controversial as it was not approved for i...
Open access
Research Article
10.9734/AIR/2015/13322